KR900005069B1 - Tooth paste compositions - Google Patents

Tooth paste compositions Download PDF

Info

Publication number
KR900005069B1
KR900005069B1 KR1019870014472A KR870014472A KR900005069B1 KR 900005069 B1 KR900005069 B1 KR 900005069B1 KR 1019870014472 A KR1019870014472 A KR 1019870014472A KR 870014472 A KR870014472 A KR 870014472A KR 900005069 B1 KR900005069 B1 KR 900005069B1
Authority
KR
South Korea
Prior art keywords
toothpaste
weight
composition
acid
sodium
Prior art date
Application number
KR1019870014472A
Other languages
Korean (ko)
Other versions
KR890009364A (en
Inventor
안호정
윤여경
정광래
우경명
Original Assignee
주식회사 럭키
허신구
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 럭키, 허신구 filed Critical 주식회사 럭키
Priority to KR1019870014472A priority Critical patent/KR900005069B1/en
Publication of KR890009364A publication Critical patent/KR890009364A/en
Application granted granted Critical
Publication of KR900005069B1 publication Critical patent/KR900005069B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

A tooth paste compsn. comprises, 0.1-2 wt.% of fluoride cpd.; 0.01- 2.0 wt.% of trinexamic acid; 0.05-5.0 wt.% of alantoin chloro hydroxy aluminum; 0.05-5.0 wt.% of tochopherol acetate; and other conventional ingradients. The compsn. may be used to prevent gingival diseases.

Description

구강 위생 증진용 치약 조성물Toothpaste composition for promoting oral hygiene

본 발명은 구강 위생 증진용 치약 조성물에 관한 것이다. 더 상세히는 불소화합물, 항플라스민제, 알란토인 유도체, 비타민 에스테르를 사용하여 충치 및 치주질환예방, 치주질환 증세 완화작용이 있으며, 함수알루미나를 사용하여 치아 세정력 및 상기 약효제의 안정성을 증진시킨 구강 위생 증진용 치약 조성물에 관한 것이다.The present invention relates to a toothpaste composition for promoting oral hygiene. More specifically, fluorine compounds, antiplasmin agents, allantoin derivatives and vitamin esters are used to prevent tooth decay and periodontal disease, and to relieve symptoms of periodontal disease. Oral hygiene improves tooth cleaning power and stability of the drug by using hydrous alumina. It relates to a toothpaste composition for promotion.

충치는 저항력이 약한 치아, 당분이 함유된 식품, 구강내 세균의 3요소에 의해서 발생되며, 구강 위생 증진은 상기 3요소를 보강하므로써 효과를 얻을 수 있다.Tooth decay is caused by the three elements of tooth, weak tooth, food containing sugar, oral bacteria, and oral hygiene can be obtained by reinforcing the three elements.

즉, 불소사용, 예방충전, 재석회화제의 사용으로 치아의 치질(저항력)을 강화하고, 비발효성 당분사용, 인공감미료사용, 칼슘과 인 강화식품의 사용으로 당분섭취를 억제하며, 면역항체, 살균제, 효소의 사용으로 구강내 세균의 살균.억제하거나 세균에 의해서 생성된 치면세균막(프라그)을 제거하는 방법등이 그 예이다.In other words, fluorine use, preventive filling, remineralization of the tooth to strengthen the hemorrhoids (resistance), non-fermented sugar use, artificial sweetener use, calcium and phosphorus fortified foods to suppress sugar intake, immune antibodies, Examples of such methods include disinfecting or suppressing oral bacteria or plaque generated by bacteria using a fungicide or enzyme.

또한, 치주질환의 원인은 통상 양치질 등의 구강 위생 유지를 위한 조치를 등한히 할 경우 세균에 의해서 생성된 치면 세균막에 칼슘, 마그네슘 등의 금속이온이 난용성 염을 형성하여 흡착되고 점차 고화되어 경도가 거의 치아와 유사한 치석을 형성하며, 이 치석은 계속해서 증가되어 잇몸과 치아의 경계면을 파고들면 양치시 쉽게 출혈을 유발하고 구강내 세균에 의해 염증을 유발시켜 각종 치주질환, 즉 치은염, 치주염, 치조농루 등을 유발시킨다.In addition, the cause of periodontal disease is usually the case of neglecting the maintenance of oral hygiene, such as brushing teeth, metal ions such as calcium, magnesium, etc. formed on the bacterial surface of the gingival bacterial membranes are adsorbed and gradually solidified to form a poorly soluble salt It forms a dental plaque almost like teeth, and the dental plaque continues to dig up the interface between the gums and teeth, causing bleeding easily when brushing teeth and inflammation caused by bacteria in the oral cavity, causing various periodontal diseases such as gingivitis, periodontitis, and alveolar. Causes untreated.

종래의 치약은 충치예방을 위해서 불소화합물을 사용했고, 치주질환예방을 위해서 영국 특허 제2,122,491A호 명세서에서는 항플라스민제인 아미노 카프론산 등을 사용함을 개시했고, 일본 특허 제86-15531A호 명세서에서는 항플라스민제와 비타민 유도체, 알란토인 유도체, 감초산을 단독 또는 혼합 사용한 것을 개시하였으며, 미국 특허 제3,514,513호 명세서에서는 알란토인 유도체를 사용했고 일본 특허 제71-10437호, 제76-41445호 명세서에서는 비타민 유도체를 사용하는 것을 개시하였으나, 이들 모두가 충치예방 및 치주질환예방효과를 기대하기 어려우며 이들이 사용한 약효제의 안정성이 불량하여 시간 경과에 따른 효과 감소가 심하며, 치아 세정력이 불량한 단점이 있다.Conventional toothpaste used a fluorine compound for the prevention of tooth decay, and in the specification of British Patent No. 2,122,491A for the prevention of periodontal disease, the use of amino capronic acid, such as an anti-plasmin agent, disclosed in the specification of Japanese Patent No. 86-15531A An antiplasmin agent, a vitamin derivative, an allantoin derivative, and licorice acid were used alone or in combination. In the specification of US Patent No. 3,514,513, an allantoin derivative was used, and in Japanese Patent Nos. 71-10437 and 76-41445, the vitamin derivative was used. Although it was disclosed that all of them are difficult to expect the effect of preventing tooth decay and periodontal disease, and the stability of the pharmacological agents used by them is poor due to the severe decrease in the effect over time, has a disadvantage of poor tooth cleaning power.

본 발명자는 상기 단점을 개선시키기 위하여 광범위하게 연구, 검토한 결과, 기존 치약 조성물에 불소화합물, 트리넥사믹산, 알란토인클로로히드록시 알루미늄, 초산토코페롤을 적정량 첨가시킨 결과, 충치, 치주질환예방 및 증세완화 효과가 우수하고, 치아 세정력 및 약효제의 시간 경과에 따른 안정성이 증진되는 점을 발견하고 본 발명을 완성하게 되었다.The present inventors have extensively researched and examined in order to improve the above disadvantages, and as a result of adding an appropriate amount of fluorine compound, trinexamic acid, allantoinchlorohydroxyaluminum and tocopherol acetate to the existing toothpaste composition, caries, prevent periodontal disease and alleviate symptoms It was found that the effect is excellent, the tooth cleaning power and the stability over time of the medicinal agent is improved and completed the present invention.

즉, 본 발명은 불소화합물 단독 또는 혼합물 0.1-2중량%, 지열효과가 우수한 트리넥사믹산[트랜스-4-(아미노메틸)-시클로헥산카르복실산] 0.01-2중량%, 수렴 및 소염효과제인 알란토인클로로히드록시 알루미늄 0.05-5중량%, 말초 혈류 개선 및 조직 노화 방지 효과제인 초산토코페롤 0.05-5중량%를 혼합 사용하고, 당 분야에서 통상의 지식을 가진자에게 공지인 침강 실리카 1-30중량%, 인산 1수소칼슘 60-10중량%, 평균입자경이 1.0-12마이크로 미터인 함수알루미나를 10-0.5중량% 함유하는 것을 특징으로 하는 구강 위생 증진용 치약 조성물이다.That is, the present invention is 0.1-2% by weight of a fluorine compound alone or a mixture, 0.01-2% by weight of trinexamic acid [trans-4- (aminomethyl) -cyclohexanecarboxylic acid] having excellent geothermal effect, and a convergent and anti-inflammatory effect agent. 0.05-5% by weight of allantoinchlorohydroxyaluminum, 0.05-5% by weight of tocopherol acetate, a peripheral blood flow improving and tissue anti-aging agent, and 1-30 weight of precipitated silica known to those skilled in the art. It is a toothpaste composition for promoting oral hygiene, characterized in that it contains 10-0.5% by weight of hydrous alumina having a%, calcium monohydrogen phosphate 60-10% by weight, and an average particle diameter of 1.0-12 micrometers.

일반적으로 치약 조성물에 사용되는 연마제로는 인산1수소칼슘, 침강실리카, 실리카겔, 탄산칼슘, 함수알루미나, 불용성 메타인산 나트륨, 피로인산칼슘, 지르코늄 실리케이트 등이 사용되며, 이들 연마제를 단독 또는 2종 이상을 혼합하여 20-70중량%를 사용하며, 바람직한 것으로는 인산1수소칼슘, 침강실리카, 함수알루미나를 단독 또는 2종 이상을 혼합하여 20-50중량%를 사용한다.Generally, abrasives used in toothpaste compositions include calcium monohydrogen phosphate, precipitated silica, silica gel, calcium carbonate, hydrous alumina, insoluble sodium metaphosphate, calcium pyrophosphate, zirconium silicate, and the like. 20-70% by weight of the mixture is used, preferably 20-50% by weight of calcium monohydrogen phosphate, precipitated silica, hydrous alumina alone or a mixture of two or more thereof.

치약 조성물의 상태유지 및 건조방지를 위하여 통상의 보습제를 사용한다.Conventional moisturizers are used to maintain the dentifrice composition and prevent drying.

보습제로는 글리세린, 소르비톨액(70% 수용액), 비결정성 소르비톨액, 프로필렌 글리콜 등이 사용되나, 바라직하기로는 글리세린, 비결정성 소르비톨액을 단독 또는 2종 이상을 혼합하여 20-70중량%를 사용한다.As the moisturizer, glycerin, sorbitol solution (70% aqueous solution), amorphous sorbitol solution, propylene glycol, etc. may be used, but preferably 20-70% by weight of glycerin and amorphous sorbitol solution alone or by mixing two or more kinds thereof. use.

결합제는 치약 조성물중 고체성분과 액체성분을 분리되지 않게 결합시키는 작용을 하며, 통상 카라기난, 크산탄껌, 카르복시 메틸 셀룰로오즈 나트륨, 카르복시 비닐 폴리머 등의 합성 고분자 물질이 사용되며, 이들을 단독 또는 2종 이상을 혼합하여 0.5-2.0중량%으로 조성시키는 것이 바람직하다. 감미제로는 삭카린나트륨, 아스파탐, 스테비오시드, 감초산 등을 들 수 있으며 당도, 감미의 질, 경제성 등을 감안할 때 적당한 것은 삭카린 나트륨, 아스파탐, 감초산을 단독 또는 2종 이상을 혼합하여 0.05-0.5중량% 조성시킨다. 치약 조성물의 제조 및 사용시 예상되는 미생물 오염에 대비하기 위하여 방부제를 사용할 수 있으며, 통상 의약품, 식품에 첨가제로서 허용된 파라옥시 안식향산 에스테르, 안식향산, 안식향산 나트륨 등을 0.05-0.25중량% 첨가시키는 것이 바람직하다. 기포제는 연마제의 세정작용을 도와주며, 약효제의 분산 및 침투를 빠르게 하고, 계면장력을 감소시켜 주므로 구강내 이물질을 쉽게 떨어지게 하는 작용이 있다.The binder serves to bind the solid component and the liquid component in the toothpaste composition without separation, and synthetic polymer materials such as carrageenan, xanthan gum, carboxy methyl cellulose sodium, and carboxy vinyl polymer are usually used. It is preferable to mix the composition to 0.5 to 2.0% by weight. Examples of sweeteners include saccharin sodium, aspartame, stevioside, and licorice. In view of sugar content, quality of sweetness, and economics, saccharin sodium, aspartame, and licorice acid are 0.05 or a mixture of two or more. -0.5% by weight of the composition. Preservatives may be used to prepare for the antimicrobial contamination expected in the manufacture and use of dentifrice compositions, and it is preferred to add 0.05-0.25% by weight of paraoxybenzoic acid esters, benzoic acid, sodium benzoate, etc., which are commonly accepted as additives in medicines and foods. . Foaming agent helps the cleaning action of the abrasive, accelerate the dispersion and penetration of the drug, and reduces the interfacial tension has the effect of easily falling foreign substances in the oral cavity.

기포제로는 주로 음이온계 계면활성제인 라우릴황산 나트륨, 라우로일살코실산 나트륨 등의 알킬황산 나트륨이 사용되고, 보조적으로 비이온성 계면활성제인 폴리옥시에틸렌 글리콜 소르비탄-지방산 에스테르, 소르비탄 지방산 에스테르, 폴리옥시에틸렌 경화피마자유, 폴리옥시에틸렌 폴리옥시 프로필렌 코폴리머 등이 사용된다.Examples of the foaming agent include sodium alkyl sulfates such as sodium lauryl sulfate and sodium lauroyl salkosylate, which are anionic surfactants, and polyoxyethylene glycol sorbitan-fatty acid esters, sorbitan fatty acid esters, and secondary nonionic surfactants Polyoxyethylene hardened castor oil, polyoxyethylene polyoxy propylene copolymer, etc. are used.

기포제의 사용량은 음이온, 비이온 계면활성제를 단독 또는 2종 이상을 혼합하여 0.5-5중량%로 조성시키는 것이 바람직하다.The amount of foaming agent used is preferably made up of 0.5-5% by weight of anionic and nonionic surfactants alone or in combination of two or more thereof.

치약 조성물의 액성을 중성 또는 목적하는 액성에 일치시키기 위한 목적으로 pH 조정제를 사용할 수 있다. pH 조정제는 통상 인산, 인산 나트륨, 구연산, 구연산 나트륨, 호박산 호박산 나트륨, 주석산 나트륨 등이 사용되며, 적당한 것으로는 인산, 인산 나트륨, 구연산, 구연산 나트륨을 단독 또는 2종 이상을 혼합하여 0.01-1.0중량%를 사용한다.PH adjusters may be used for the purpose of matching the liquidity of the dentifrice composition to neutral or desired liquidity. As the pH adjuster, phosphoric acid, sodium phosphate, citric acid, sodium citrate, sodium succinate, sodium stannate, etc. are usually used, and suitable ones are 0.01-1.0 wt% of phosphoric acid, sodium phosphate, citric acid, sodium citrate alone or a mixture of two or more thereof. Use%.

치약 조성물중 연마제·기포제에서 기인된 불유쾌한 맛을 은폐시키고 양치시 청량감 및 개운한 느낌을 주기 위해서 향료의 사용이 필수적이다. 향료는 페파민트 오일, 스피아민트 오일, 맨틀, 카르본(Carvone)등이 주로 사용되며, 치약의 사용 목적에 따라 게피 알데히드, 살리실산 메틸, 레몬오일, 오이게놀, 유칼립톨 등을 혼합 사용하기도 하며 적당한 사용량은 0.5-1.5중량%이다.The use of fragrance is essential to conceal the unpleasant taste caused by the abrasives and foaming agents in the toothpaste composition and to give a refreshing and refreshing feeling when brushing teeth. The main flavors are peppermint oil, spearmint oil, mantle and carbon (Carvone), and depending on the purpose of the toothpaste, you may use a mixture of gepyaldehyde, methyl salicylate, lemon oil, eugenol and eucalyptol. The amount used is 0.5-1.5 wt%.

[실시예 1-3]Example 1-3

다음 표 1과 같은 성분을 주성분으로 하여 본 발명의 치약 조성물을 제조하였다.Toothpaste composition of the present invention was prepared using the ingredients shown in Table 1 as a main component.

[비교예 1-5]Comparative Example 1-5

다음 표 1과 같은 성분을 주성분으로 하여 기존의 치약 조성물을 제조하였다.Next, the toothpaste composition was prepared using the ingredients shown in Table 1 as main components.

[표 1]TABLE 1

Figure kpo00001
Figure kpo00001

[실험예 1]Experimental Example 1

[본 발명 치약(실시예 1-3)의 효능·효과 임상시험][Efficacy and Effect Clinical Trial of Toothpaste of the Invention (Examples 1-3)]

본 발명 치약을 가지고 임상시험을 실시한 결과는 다음과 같다.(대한 구강 보건학회지 Vol 12, No.1.1988)The results of clinical trials using the toothpaste of the present invention are as follows. (Korean Journal of Oral Health Vol 12, No.1.1988)

1) 실험 대상자 ; 19-20세인 S전문대생 240명을 실험대상으로 함.1) subjects; The subjects were 240 S professional college students aged 19-20 years.

2) 실험 대상 치약 : 트라넥사믹산, 알란토인클로로히드록시 알루미늄, 초산토코페롤 및 제1불화인산 나트륨을 배합한 치약(본 발명 치약)과 이들 물질을 함유하지 않은 치약(대조치약)을 비교 실험함.2) Toothpaste to be tested: Toothpaste (traditional toothpaste) containing a combination of tranexamic acid, allantoinchlorohydroxyaluminum, tocopherol acetate and sodium monofluorophosphate (toothpaste of the present invention) and a toothpaste (control toothpaste) not containing these substances were compared.

3) 실험 방법 : 실험 대상자를 실험군(본 발명 치약 사용군) 120명, 대조군 120명으로 구분하고, 치주조직을 검사하여 치은염 유병단위 치주조직을 조사하여 제3대구치를 제외한 치은염 검사결과를 기록부에 기록하였다. 아울러 모든 대상자에게 중강도 강모 칫솔을 배부하고 해당 치약을 사용하여 양치질하게 하고 20일 후 및 40일 후에 치주조직을 검사하여 그 결과를 가지고 비교하였다.3) Experimental Method: The test subjects were divided into 120 experimental groups (the present invention used toothpaste group) and 120 control groups. Recorded. In addition, all subjects were given a medium-strength bristle toothbrush and brushed with the toothpaste. After 20 and 40 days, the periodontal tissues were examined and compared with the results.

4) 실험 결과4) Experiment result

치은염 치료율(%)은 아래와 같다.Treatment rate of gingivitis (%) is as follows.

Figure kpo00002
Figure kpo00002

5) 고찰5) Consideration

4종의 약효제를 함유한 본 발명 치약의 치은염 예방 및 완화 효과는 실험시작 20일 후 및 40일 후에서 모두 상용치약(대조치약)보다 월등히 양호했다.The gingivitis prevention and alleviating effect of the toothpaste of the present invention containing four medicinal agents was significantly better than the common toothpaste (control toothpaste) after 20 days and 40 days after the start of the experiment.

[실험예 2]Experimental Example 2

[본 발명 치약(실시예 1,2)과 비교치약(비교예 5)의 치주질환예방 효능·효과 비교 실험][Comparison Experiment and Effect of Periodontal Disease Prevention of Toothpaste (Examples 1, 2) and Comparative Toothpaste (Comparative Example 5)]

본 발명 치약과 대조치약을 가지고 매일 3회씩(각 3분간) 20일간 양치질하게 하고 잇몸의 색상 변화를 측정하여 잇몸의 건강 상태 유지 및 개선효과를 비교 시험하였다. 색상변화는 일본 전색의 ∑-80 색차계를 사용하였다.The toothpaste and the control toothpaste of the present invention were brushed three times daily (for 3 minutes each) for 20 days and the color change of the gum was measured to compare and maintain the health condition and improvement effect of the gums. For color change, ∑-80 color difference meter was used.

Figure kpo00003
Figure kpo00003

통상 건강한 잇몸일수록 명도지수가 크고, 적색도가 높으며 황색도가 낮다.Normally, healthy gums have a higher brightness index, higher redness, and lower yellowness.

즉 선명한 홍색을 나타내게 된다.That is, a bright red color will appear.

본 실험을 통해서 나타난 수치를 서로 비교한 결과는 다음과 같다.The results of this experiment were compared with each other.

Figure kpo00004
Figure kpo00004

실험 결과로 볼 때 명도지수 증가는 실시예 치약이 비교예 보다 평균 4.2, 4.7, 4.0 및 4.4 증가하였으며, 적색도는 평균 5.0, 6.0, 4.8 및 3.6이 증가했으며, 황색도 증가는 0.3, 1.0, 0.4 및 0.8이 감소되어 결과적으로 실시예 치약을 사용한 경우가 더욱 잇몸 색상이 건강한 색상인 선홍색을 띄는 것으로 나타나 치주질환예방 및 치료 효과가 우수한 것으로 나타났다. 즉, 실시예 1의 조성은 이원성 불소제공 시스템이 아닌 일원성 불소시스템, 트리넥사믹산, 초산토코페롤, 알란토인클로로히드록시 알루미늄의 주성분이 공지의 치약조성물에 배합되었을 때, 불소화합물과 트리넥사믹산이 함유된 치약 조성물(비교예 1), 불소화합물과 알란토인클로로히드록시 알루미늄이 함유된 치약 조성물(비교예 2), 알란토인클로로 히드록시 알루미늄이 배합된 치약 조성물(비교예 4), 트리넥사믹산, 알란토인 및 토코페롤이 함유된 치약 조성물(비교예 5)을 비교하였을 때, 상기 표에서 나타난 바와같이 본 발명의 치약 조성물이 비교예의 조성물보다 탁월한 치주질환예방 및 치료효과가 우수함을 나타낸다.As a result of the experiment, the brightness index was increased by 4.2, 4.7, 4.0 and 4.4 on average in toothpaste compared to the comparative example, the redness increased by 5.0, 6.0, 4.8 and 3.6 on average and the increase in yellowness was 0.3, 1.0, 0.4 As a result, the toothpaste was shown to have a bright red color, which is a healthy color, resulting in excellent periodontal disease prevention and treatment. That is, the composition of Example 1 is a fluorine compound and trinexamic acid when the main component of the mono-fluorine system, trinexamic acid, tocopherol acetate, allantoin chlorohydroxy aluminum, which is not a binary fluorine providing system, is blended with a known toothpaste composition. Toothpaste composition (Comparative Example 1), Toothpaste composition containing fluorine compound and allantoin chlorohydroxy aluminum (Comparative Example 2), Toothpaste composition containing allantoin chlorohydroxy aluminum (Comparative Example 4), Trinexamic acid, Allantoin And when comparing the toothpaste composition containing tocopherol (Comparative Example 5), as shown in the table shows that the toothpaste composition of the present invention is superior to the composition of the comparative example, excellent periodontal disease prevention and treatment effect.

[실험 3][Experiment 3]

[본 발명 치약(실시예 1-3)과 비교예 1,2,3,5의 세정력(Cleaning Power)비교 시험][Comparison Test of Cleaning Power of Invention Toothpaste (Examples 1-3) and Comparative Examples 1,2,3,5]

1) 실험준비1) Preparation for experiment

담배 2갑(40개피)을 속실렛장치에서 아세톤을 용매로 하여 타르(Tar)를 추출하고 감압 증류하여 아세톤을 제거한 후 한쪽면에 유약을 발라서 구운 소형 타일(3×3cm)의 매끄러운 면에 얇게 바른후 60℃에서 건조하고 물속에 2-3일 담그었다가 꺼내어 140℃에서 24시간 건조한 후 시험에 사용한다.Two packs of cigarettes (40 packs) were extracted using acetone as a solvent in a soxhlet apparatus, tar was extracted, distilled under reduced pressure, acetone was removed, and glaze was applied on one side of the thin tile (3 × 3cm) to make a thin layer. After drying, it is dried at 60 ℃, soaked in water for 2-3 days, taken out, dried at 140 ℃ for 24 hours, and used for testing.

2) 조작2) operation

타일을 칫솔이 장치된 연마력 시험기에 고정하고 치약 20g과 글리세린 20g을 혼합한 용액을 넣고 250g의 하중으로 1500회 왕복 칫솔질한후 꺼내어 물로 조심스럽게 닦아준후 건조한다. 이때 사용한 칫솔은 중강도의 강모의 칫솔을 사용했다.The tile is fixed to an abrasive tester equipped with a toothbrush, and a solution containing 20 g of toothpaste and 20 g of glycerin is mixed, and after reciprocating brushing with a load of 250 g 1500 times, it is taken out and carefully wiped with water and dried. The toothbrush used was a toothbrush of medium strength bristles.

3) 평가방법3) Evaluation method

Figure kpo00005
Figure kpo00005

시험이 끝난 타일위에 투명 모눈종이(2×2㎜ 단위 눈금)를 놓고 타르가 제거된 면적을 측정하여 실시예의 치약과 비교예의 치약 세정력을 비교 시험함.A transparent grid paper (2 × 2 mm scale) was placed on the finished tile, and the tar removed area was measured to compare the toothpaste cleaning example of the example and the toothpaste cleaning power of the comparative example.

4) 실험결과4) Experiment result

Figure kpo00006
Figure kpo00006

5) 고찰 : 세정력 비교 시험 결과 실시예 2를 제외하고는 연마력이 비슷한 수준이었으나 세정력은 실시예 1이 가장 양호했으며 비교예의 처방간에는 거의 차이가 없었다. 상기 결과로 볼때에 실시예 처방에 함수알루미나를 적당량 첨가시 세정력이 증가하는 것을 알수 있다.5) Discussion: As a result of the comparative test of the cleaning power, the polishing power was similar except for Example 2, but the cleaning power of Example 1 was the best and there was almost no difference between the formulations of the comparative example. In view of the above results, it can be seen that the cleaning power increases when an appropriate amount of hydrous alumina is added to the example formulation.

[실험예 4]Experimental Example 4

[약효제의 안정성 비교 시험][Stability Comparison Test of Drug]

1. 실시예 1과 비교예 1,2의 시간 경과에 따른 잔존 유효 불소량 비교 시험1. Comparative test of residual effective fluorine content over time of Example 1 and Comparative Examples 1 and 2

실시예 1과 비교예 1,2의 치약을 실온과 50℃ 항온기에서 보관하면서 시간 경과에 따른 유효불소의 함량을 오리온 이온 메타(Orion Ionmeter Model 701A)를 이용하여 전위차 적정법으로 시험한 결과는 다음과 같다.The toothpaste of Example 1 and Comparative Examples 1 and 2 were stored at room temperature and 50 ° C. in a thermostat, and the contents of effective fluorine over time were tested by potentiometric titration using Orion ion meta (Orion Ionmeter Model 701A). same.

[시험결과][Test result]

Figure kpo00007
Figure kpo00007

실시예 1 치약의 경우 함수알루미나와 침강 실리카를 소량 첨가한 결과 동일 연마제 처방인 비교예 1,2보다 시간 경과에 따른 유효불소 잔존량이 월등히 양호한 결과를 얻었다.Example 1 In the case of toothpaste, when a small amount of hydrous alumina and precipitated silica were added, the effective fluorine remaining amount over time was much better than that of Comparative Examples 1 and 2, which are the same abrasive formulations.

2. 실시예 1과 비교예 5의 시간 경과에 따른 알란토인클로로히드록시 알루미늄(비교예에서는 알란토인)과 초산토코페롤(비교예에서는 토코페롤)의 안정성 비교 시험.2. Stability comparison test of allantoinchlorohydroxyaluminum (allantoin in the comparative example) and tocopherol acetate (tocopherol in the comparative example) over time of Example 1 and Comparative Example 5.

상기 두 치약을 실온 및 50℃에 보관하면서 시간 경과에 따른 잔존량의 변화를 고성능 액체 크로마토그라피법으로 분석 시험한 결과는 다음과 같다.The two toothpastes were stored at room temperature and 50 ° C., and the results of the analysis of the change in the residual amount over time by high performance liquid chromatography were as follows.

[시험결과][Test result]

Figure kpo00008
Figure kpo00008

실시예 1은 알란토인클로로히드록시 알루미늄과 초산토코페롤 함유Example 1 contains allantoinchlorohydroxyaluminum and tocopherol acetate

실시예 1과 비교예 5의 약효제 안정성 시험 결과, 알란토인클로로히드록시 알루미늄과 초산토코페롤을 배합한 실시예 1의 조성물이 우수한 것으로 나타났다.The drug stability test of Example 1 and Comparative Example 5 showed that the composition of Example 1 in which allantoinchlorohydroxyaluminum and tocopherol acetate were combined was excellent.

즉, 알란토인과 토코페롤 사용시보다는 알란토인클로로히드록시 알루미늄과 초산토코페롤 사용시가 이들 약효제의 안정성이 양호한 것으로 나타났다.In other words, the use of allantoin chlorohydroxy aluminum and tocopherol acetate was found to be more stable than the use of allantoin and tocopherol.

이상에서 본 발명을 설명한 바와같이, 본 발명의 조성물은 불소화합물(일원성, 이원성 불소시스템의 선택에 관계없음), 알란토인클로로히드록시 알루미늄, 초산토코페롤 및 트리넥사믹산을 공지의 치약 조성물을 배합시킨 것으로서, 시판품 및 비교품보다 충치예방 효과뿐만 아니라, 치주질환, 치은염의 예방 및 치료에 탁월한 효과를 나타내고 또한 경시변화에 대한 안정성도 우수함을 나타낸다.As described above, the composition of the present invention comprises a fluorine compound (regardless of the choice of mono- or binary fluorine systems), allantoin chlorohydroxy aluminum, tocopherol acetate, and trinexamic acid in combination with a known toothpaste composition. As a result, it exhibits not only the effect of preventing tooth decay, but also the effect of preventing and treating periodontal disease and gingivitis as well as the stability over time.

Claims (1)

불소성분 화합물이 함유된 공지의 치약 조성물에, 트리넥사믹산 0.01-2.0중량%, 알란토인클로로히드록시 알루미늄 0.05-5.0중량%, 초산토코페롤 0.05-5.0중량%를 조성시킴을 특징으로 하는 구강 위생 증진용 치약 조성물.Toothpaste composition containing a fluorine-containing compound, 0.01-2.0% by weight of trinexamic acid, 0.05-5.0% by weight of allantoinchlorohydroxy aluminum, 0.05-5.0% by weight of tocopherol acetate for improving oral hygiene Toothpaste Composition.
KR1019870014472A 1987-12-18 1987-12-18 Tooth paste compositions KR900005069B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019870014472A KR900005069B1 (en) 1987-12-18 1987-12-18 Tooth paste compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019870014472A KR900005069B1 (en) 1987-12-18 1987-12-18 Tooth paste compositions

Publications (2)

Publication Number Publication Date
KR890009364A KR890009364A (en) 1989-08-01
KR900005069B1 true KR900005069B1 (en) 1990-07-19

Family

ID=19267059

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870014472A KR900005069B1 (en) 1987-12-18 1987-12-18 Tooth paste compositions

Country Status (1)

Country Link
KR (1) KR900005069B1 (en)

Also Published As

Publication number Publication date
KR890009364A (en) 1989-08-01

Similar Documents

Publication Publication Date Title
US3897548A (en) Oral compositions for retarding the formation of dental plaque and methods of utilization thereof
JP2000154127A (en) Composition for oral cavity
US4853213A (en) Use of periwinkle in oral hygiene
RU2457829C2 (en) Mineral and vitamin complex for strengthening tooth enamel, composition for oral cavity hygiene and toothpaste
JP2005008579A (en) Agent for inhibiting coaggregation of oral bacteria
KR101336726B1 (en) Composition of toothpaste which contains flower fragments
JPS5835962B2 (en) toothpaste composition
WO2000025737A1 (en) Oral composition exhibiting improved uptake of antibacterial compounds
US5316760A (en) Mouth-care products
KR900005069B1 (en) Tooth paste compositions
KR20040081936A (en) Dental composition for antiplaque and antigingivity
JPH1087502A (en) Composition for oral cavity
KR0119269B1 (en) Plaque disclosing agent
KR890004557B1 (en) Oral hygiene compositions
Schaeken et al. Control of calculus formation by a dentifrice containing calcium lactate
JP2726490B2 (en) Oral composition
KR0179523B1 (en) Dentifrice composition for gingivitis curing
KR100564231B1 (en) Toothpaste composition comprising soft bead
KR0170108B1 (en) Toothpaste composition containing guaiac and coloring compositions
KR900006826B1 (en) Tooth paste composition
KR100807079B1 (en) Toothpaste Containing Plant Leaf Fragment
JP2000229823A (en) Composition for oral cavity
JP3667472B2 (en) Oral composition
JPH06219930A (en) Composition for oral cavity
JP7258206B1 (en) oral composition

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

AMND Amendment
G160 Decision to publish patent application
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970624

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee